Literature DB >> 872308

Follow-up technetium-99m stannous pyrophosphate myocardial scintigrams after acute myocardial infarction.

H G Olson, K P Lyons, W S Aronow, W T Brown, R S Greenfield.   

Abstract

Technetium-99m stannous pyrophosphate (99mTc-PYP) myocardial scintigrams were obtained in 68 patients during acute myocardial infarction (AMI) and at follow-up 15.9 +/- 8.8 weeks later. All patients with AMI had a positive scintigram (2+ or greater); only one of 46 control patients (2%) had a positive (2+) scintigram. At follow-up scintigraphy 6 to 37 weeks following AMI, 57% of patients had a persistently positive scintigram even though recurrent AMI was suspected in only one of these patients. Patients with persistently positive scintigrams tended to have more severe disease as evidenced by compensated congested heart failure (41%) persistent angina (77%), and ECG evidence of ventricular dyssynergy (51%), We conclude that 1) in patients with prior AMI, a 2+ abnormality on 99mTc-PYP scintigram may not represent new AMI; 2) a persistently positive 99mTc- PYP scintigram may have prognostic implications since it occurs predominantly in patients with severe symptomatic coronary disease.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 872308     DOI: 10.1161/01.cir.56.2.181

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  7 in total

Review 1.  Role of nuclear cardiac imaging in myocardial infarction: postinfarction risk stratification.

Authors:  John J Mahmarian; Girish Dwivedi; Tultul Lahiri
Journal:  J Nucl Cardiol       Date:  2004 Mar-Apr       Impact factor: 5.952

2.  Myocardial scintigraphy with infarct-avid tracers.

Authors:  B L Holman; J Wynne
Journal:  Cardiovasc Radiol       Date:  1979-09

3.  Technetium 99m glucarate: what will be its clinical role?

Authors:  M C Gerson; A J McGoron
Journal:  J Nucl Cardiol       Date:  1997 Jul-Aug       Impact factor: 5.952

4.  Standardization of 99mTechnetium pyrophosphate imaging methodology to diagnose TTR cardiac amyloidosis.

Authors:  Sabahat Bokhari; Rachelle Morgenstern; Richard Weinberg; Mona Kinkhabwala; Demetrios Panagiotou; Adam Castano; Albert DeLuca; Andrew Kontak; Zhezhen Jin; Mathew S Maurer
Journal:  J Nucl Cardiol       Date:  2016-08-31       Impact factor: 5.952

5.  Underestimation of equilibrium radionuclide left ventricular ejection fraction due to myocardial uptake of 99mTc.

Authors:  P F Hoilund-Carlsen; J Marving
Journal:  Eur J Nucl Med       Date:  1984

6.  Cardiovascular nuclear medicine and intensive care.

Authors:  P J Ell; R M Donaldson
Journal:  Intensive Care Med       Date:  1978-07       Impact factor: 17.440

7.  Infarct avid imaging study in the radionuclide diagnosis of acute myocardial infarction.

Authors:  R L van Heertum
Journal:  Bull N Y Acad Med       Date:  1981-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.